KEMPHARM, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 77.46B | ||||||
| 8.94B | ||||||
| 4.28B | ||||||
| 4.18B | ||||||
| 4.11B | - | - |
